GlucoTrack Inc. (GCTK) Financial Statements (2025 and earlier)
Company Profile
Business Address |
301 RT 17 NORTH RUTHERFORD, NJ 07070 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 4,492 | 2,312 | 6,062 | 9,823 | 419 | 97 | |||
Cash and cash equivalents | 4,492 | 2,312 | 6,062 | 9,823 | 419 | 97 | |||
Receivables | 66 | 70 | 23 | ||||||
Inventory, net of allowances, customer advances and progress billings | 284 | 185 | 171 | ||||||
Inventory | 284 | 185 | 171 | ||||||
Other current assets | 376 | 67 | 43 | 56 | 45 | 23 | |||
Total current assets: | 4,868 | 2,379 | 6,105 | 10,229 | 718 | 314 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 40 | 166 | 187 | ✕ | |||||
Property, plant and equipment | 27 | 40 | 69 | 149 | 134 | 150 | |||
Restricted cash and investments | 10 | 19 | 51 | 62 | 57 | 53 | |||
Other undisclosed noncurrent assets | 186 | 172 | |||||||
Total noncurrent assets: | 37 | 59 | 160 | 377 | 564 | 374 | |||
TOTAL ASSETS: | 4,905 | 2,438 | 6,265 | 10,606 | 1,282 | 688 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 839 | 672 | 631 | 869 | 1,534 | 2,064 | |||
Accounts payable | 839 | 672 | 631 | 869 | 1,534 | 2,064 | |||
Debt | 142 | ||||||||
Other liabilities | 673 | 341 | 229 | 392 | 596 | 1,157 | |||
Other undisclosed current liabilities | 23 | 84 | |||||||
Total current liabilities: | 1,512 | 1,013 | 883 | 1,345 | 2,272 | 3,222 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 17 | 82 | 45 | ||||||
Liabilities, other than long-term debt | 196 | 195 | 210 | 197 | 377 | 340 | |||
Liability, pension and other postretirement and postemployment benefits | 186 | 172 | |||||||
Due to related parties | ✕ | ✕ | 195 | 210 | 197 | 190 | 168 | ||
Other liabilities | 196 | ||||||||
Operating lease, liability | 17 | 82 | 45 | ✕ | |||||
Total noncurrent liabilities: | 196 | 195 | 227 | 279 | 422 | 340 | |||
Total liabilities: | 1,708 | 1,208 | 1,110 | 1,624 | 2,694 | 3,561 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 3,197 | 1,230 | 5,155 | 8,982 | (1,412) | (2,873) | |||
Common stock | 20 | 15 | 15 | 201 | 163 | 142 | |||
Additional paid in capital | 112,966 | 103,095 | 102,612 | 102,165 | 89,004 | 84,008 | |||
Accumulated other comprehensive income (loss) | 16 | 17 | (6) | 15 | 124 | 164 | |||
Accumulated deficit | (109,853) | (101,901) | (97,466) | (93,399) | (90,703) | (87,187) | |||
Other undisclosed equity, attributable to parent | 48 | 4 | |||||||
Total equity: | 3,197 | 1,230 | 5,155 | 8,982 | (1,412) | (2,873) | |||
TOTAL LIABILITIES AND EQUITY: | 4,905 | 2,438 | 6,265 | 10,606 | 1,282 | 688 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 209 | 43 | ||||||
Cost of revenue (Cost of Goods and Services Sold) | (321) | |||||||
Gross profit: | (321) | 209 | 43 | |||||
Operating expenses | (7,104) | (4,432) | (4,040) | (3,132) | (3,714) | (6,582) | ||
Other undisclosed operating income | 321 | 6,264 | 13,077 | |||||
Operating income (loss): | (7,104) | (4,432) | (4,040) | 3,132 | (3,506) | 6,539 | ||
Nonoperating income (expense) | (14) | (53) | 338 | (11) | (177) | |||
Loss, foreign currency transaction, before tax | (32) | |||||||
Other nonoperating income (expense) | (14) | (53) | 338 | 11 | ||||
Income (loss) from continuing operations before equity method investments, income taxes: | (7,104) | (4,446) | (4,093) | 3,470 | (3,516) | 6,362 | ||
Other undisclosed loss from continuing operations before income taxes | (6,166) | (0) | (13,077) | |||||
Loss from continuing operations: | (7,104) | (4,446) | (4,093) | (2,696) | (3,516) | (6,715) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (4,093) | (2,696) | (3,516) | (6,715) | |
Net loss: | (7,104) | (4,446) | (4,093) | (2,696) | (3,516) | (6,715) | ||
Other undisclosed net income (loss) attributable to parent | 7 | 11 | 26 | 5,392 | 0 | 13,431 | ||
Net income (loss) attributable to parent: | (7,097) | (4,435) | (4,067) | 2,696 | (3,516) | 6,715 | ||
Other undisclosed net income (loss) available to common stockholders, basic | 15,049 | (5,392) | (45,534) | |||||
Net income (loss) available to common stockholders, diluted: | 7,952 | (4,435) | (4,067) | (2,696) | (3,516) | (38,818) |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (7,104) | (4,446) | (4,093) | (2,696) | (3,516) | (6,715) | ||
Other comprehensive income (loss) | (1) | 23 | (21) | (109) | (40) | 54 | ||
Comprehensive loss: | (7,105) | (4,423) | (4,114) | (2,805) | (3,556) | (6,662) | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 7 | 8,835 | 26 | 5,610 | 0 | 13,324 | ||
Comprehensive income (loss), net of tax, attributable to parent: | (7,098) | 4,412 | (4,088) | 2,805 | (3,556) | 6,662 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.